KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Cash from Investing Activities (2018 - 2025)

Moderna (MRNA) has disclosed Cash from Investing Activities for 8 consecutive years, with -$48.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities rose 91.09% to -$48.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.9 billion, a 0.15% change, with the full-year FY2025 number at $1.9 billion, changed 0.15% from a year prior.
  • Cash from Investing Activities was -$48.0 million for Q4 2025 at Moderna, down from $700.0 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $2.0 billion in Q1 2023 to a low of -$3.9 billion in Q1 2022.
  • A 5-year average of -$279.9 million and a median of $35.0 million in 2024 define the central range for Cash from Investing Activities.
  • Peak YoY movement for Cash from Investing Activities: plummeted 29930.77% in 2021, then surged 518.64% in 2025.
  • Moderna's Cash from Investing Activities stood at -$1.1 billion in 2021, then grew by 7.91% to -$1.0 billion in 2022, then soared by 48.66% to -$538.0 million in 2023, then decreased by 0.19% to -$539.0 million in 2024, then skyrocketed by 91.09% to -$48.0 million in 2025.
  • Per Business Quant, the three most recent readings for MRNA's Cash from Investing Activities are -$48.0 million (Q4 2025), $700.0 million (Q3 2025), and $564.0 million (Q2 2025).